Search

everythinglearnresearchcommunity

for

Search:↓

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

AS-OCT is crucial for diagnosing VZV interstitial keratitis and avoiding unnecessary treatments.

Statins do not help improve alopecia areata.

Statins do not help improve alopecia areata.

Severe COVID-19 increases the risk of hair loss.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Trichoscopy effectively shows early positive effects of minoxidil in male pattern hair loss, improving patient satisfaction.

Bariatric surgery improved quality of life and health in six months, but hair loss was common.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Androgenetic alopecia doesn't increase the risk of heart-related health issues.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Higher air pollution increases the risk of alopecia areata.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.